ZNTL · Zentalis Pharmaceuticals, Inc.
$3.56
-0.59 (-14.22%)
At close · Aug 14
Market Cap
$255.15M
Shares
71.67M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2021-05 | — | $75,000,000 | $75,000,000 as of 2025-09-30 | — | 10-Q , filed 2025-11-10 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2025-12-31 | $9,976,000 | 10-K, filed 2026-03-26 | ||
Key facts
CIK
1725160
CUSIP
98943L107
13F (30d)
114 filings
111 filers
Visit website
Investor relations